NCT06120283 2026-04-15BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting399 enrolled
NCT04553133 2026-04-13PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting157 enrolled
NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled